Particulars Number Cytogenetic Response (Peripheral Blood)
 Complete   Partial      No response
  Gender Male 16 14 01 01
Female 14 11 01 02
Age >45 11 10 00 01
<45 19 15 02 02
Dwelling Urban 12 09 01 02
Rural 18 16 01 01
TLC+Spleen (Baseline) Raised 30 ------ ------ ------
Normal 30 ------ ------ ------
BCR-ABL q-PCR value (Baseline) >80% 30 ------ ------ ------
<80% 00 ------ ------ ------
 Karyotyping (Baseline) Ph+ve(>80%) 30 ------ ------ ------
Ph-ve 00 ------ ------ ------
TLC+Spleen (Follow up) Raised 03      00 00 03
Normal 27 25 02 00
BCR-ABL q-PCR value (Follow-up) 0-40 % 25 ------ ------
40-60% ------ 02 ------
60-80% ------ ------ 03
Karyotyping (Follow up) Ph+ve 03 00 00 03
Ph-ve 27 25 02 00
Table 2: Patients particulars and ‘Peripheral blood cytogenetic response’ at 6 months of ‘Imatinib’ treatment.